Rescue breathing tied to better pediatric arrest survival; machine-learning score flags poor outcome; FDA clears ROTEM trauma cartridge

Two defibrillator paddles resting side by side on a steel cart, their coiled cords looping away.

A Japanese registry study of 26,785 children published Nov. 19 in JAMA Network Open tied CPR with rescue breathing to better outcomes than compression-only CPR after out-of-hospital cardiac arrest.

A French registry validated the MIRA-29 machine-learning prehospital score for poor neurologic outcome, the Food and Drug Administration (FDA) cleared Werfen's ROTEM sigma complete cartridge for adult trauma, and the Centers for Disease Control and Prevention (CDC) reported rising flu activity.

  • Research Nov 19, 2026
    A JAMA Network Open registry study from Japan published Nov. 19 included 26,785 children with out-of-hospital cardiac arrest. Thirty-day survival with favorable neurologic outcome was 16.0% with bystander CPR that included rescue breathing, 9.5% with compression-only CPR and 3.6% with no bystander CPR, an adjusted risk ratio of 1.71 (95% CI 1.57 to 1.86). The authors said the results support the continued importance of rescue breathing.
  • AI Nov 17, 2026
    A Resuscitation study published Nov. 17 derived the MIRA-29 score, refined with machine-learning and genetic algorithms, in a prospective cohort of 1,099 adults after out-of-hospital cardiac arrest, of whom 85 (7.7%) had a favorable neurologic outcome, and validated it in 82,696 patients from the French national cardiac arrest registry. External validation showed precision of 0.86 and recall of 0.88, with specificity of 0.99 for a poor neurologic prognosis, according to the authors. They said the score can identify patients with an extremely high probability of poor outcome early in prehospital care.
  • FDA Nov 17, 2026
    Werfen said Nov. 17 that the Food and Drug Administration (FDA) granted 510(k) clearance for the ROTEM sigma complete cartridge for use in trauma, extending the point-of-care viscoelastic system beyond cardiovascular surgery and liver transplantation in the U.S. The cartridge is cleared to assess hemorrhage and thrombosis in trauma in patients 21 and older and is not intended for prehospital use, according to the company. The release included no clinical performance data.
    Source: Werfen
  • Research Nov 17, 2026
    A Resuscitation registry study published Nov. 17 examined 9,413 out-of-hospital cardiac arrests from 2015 to 2024 in Sweden's Västra Götaland Region, where the response system includes drones carrying automated external defibrillators (AEDs). Emergency medical services (EMS) attached the first AED in 72% of cases. Thirty-day survival was 28% when bystanders attached the AED and 9.0% when EMS did, and bystander attachment was associated with higher odds of survival after adjustment (odds ratio 2.25; 95% CI 1.77 to 2.85), the authors said.
  • Public health Nov 20, 2026
    The Centers for Disease Control and Prevention (CDC) said in its Nov. 20 FluView report that seasonal flu activity continues to increase nationally. In the week ending Nov. 14, 11.8% of clinical laboratory specimens tested positive for influenza, and 352 of 365 subtyped influenza A viruses (96.4%) were A(H1N1)pdm09. Visits for influenza-like illness reached 3.8%, and seven pediatric flu deaths have been reported this season. CDC recommends annual vaccination from age 6 months and says antivirals should be started as early as possible.
    Source: CDC
  • FDA Nov 19, 2026
    The Food and Drug Administration (FDA) posted an early alert Nov. 19 on B. Braun's Caresite Micro luer access device, whose internal piston can remain depressed after a male luer is disconnected, leaving the valve open. Possible consequences include blood loss, interruption or delay of therapy and air embolism, which may cause serious injury and, rarely, death. B. Braun told users to inspect devices after disconnection and replace any that leak or show backflow; it reported no serious injuries or deaths as of Nov. 3.
    Source: FDA
  • Public health Nov 17, 2026
    The U.S. has lost the measles elimination status it earned 26 years ago, officials announced Nov. 17, after the Pan American Health Organization (PAHO) found the virus had circulated uninterrupted for more than a year, Healio reported; news reports of the decision appeared Nov. 14. Countries that lose the status must submit a plan to PAHO for getting measles back under control. In a joint statement, Centers for Disease Control and Prevention (CDC) Director Dr. Erica Schwartz said, "The measles elimination designation is not what protects Americans. Vaccination does."

The weekly innovation roundup for emergency medicine, published every Sunday for the week before; every item links to its sources. Latest emergency medicine news · All specialties

Latest news

Tagged emergency medicine, from the daily briefing

  1. Virginia reports a young child's measles death, its first this year, as U.S. cases pass 5,800
  2. EMS, surgeon, emergency and pediatric groups update guidance on pediatric traumatic out-of-hospital arrest
  3. ACEP joint position statement covers prehospital care of children in traumatic out-of-hospital circulatory arrest

See all the latest news